Shares of PURE Bioscience (NASDAQL PURE) are falling this morning by 6.45%, trading at $2.61, after the company reported a $0.05 per share loss for the fourth quarter. Notably, total revenues, which ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20260316962124/en/ The articles, information, and content displayed on this webpage ...
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental ...
EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is set to unveil its newest food safety ...
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, has entered into a strategic alliance ...
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. There have been no specific sales or earnings ...
PURE Bioscience Announces Closing of Public Offering of 4.3 Million Shares of Common Stock, Including the Underwriter’s Over-Allotment Option , the creator of the patented silver dihydrogen citrate ...
EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (PURE) (OTCQB: PURE) (“PURE” or the “Company”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today ...
EL CAJON, Calif., March 16, 2026--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results